Cibus, Inc. (NASDAQ:CBUS) Short Interest Update

Cibus, Inc. (NASDAQ:CBUS) saw a significant increase in short interest during the month of June. As of June 15th, there was short interest totalling 878,800 shares, an increase of 33.3% from the May 31st total of 659,100 shares. Currently, 5.8% of the shares of the stock are sold short. Based on an average trading volume of 111,500 shares, the days-to-cover ratio is presently 7.9 days.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reaffirmed a “buy” rating and set a $25.00 price target on shares of Cibus in a research note on Friday, May 10th.

Cibus Price Performance

CBUS traded down $0.58 during trading on Monday, hitting $9.27. The company’s stock had a trading volume of 246,410 shares, compared to its average volume of 100,506. Cibus has a twelve month low of $8.31 and a twelve month high of $24.61. The stock has a market cap of $199.72 million, a PE ratio of -0.51 and a beta of 1.92. The firm’s 50 day moving average price is $13.90 and its 200-day moving average price is $16.78.

Cibus (NASDAQ:CBUS) last released its earnings results on Thursday, May 9th. The company reported ($1.12) EPS for the quarter, missing the consensus estimate of ($1.01) by ($0.11). Cibus had a negative net margin of 12,313.28% and a negative return on equity of 23.33%. The business had revenue of $0.55 million during the quarter, compared to analyst estimates of $0.40 million. During the same quarter in the previous year, the company posted ($5.45) earnings per share. Equities analysts anticipate that Cibus will post -3.22 earnings per share for the current year.

Institutional Investors Weigh In On Cibus

Hedge funds have recently modified their holdings of the stock. FMR LLC raised its stake in Cibus by 0.4% during the third quarter. FMR LLC now owns 2,496,152 shares of the company’s stock worth $45,480,000 after purchasing an additional 8,763 shares during the period. FineMark National Bank & Trust purchased a new position in Cibus in the third quarter valued at approximately $300,000. Citigroup Inc. acquired a new position in Cibus during the third quarter valued at approximately $199,000. Blue Trust Inc. purchased a new stake in Cibus during the fourth quarter worth approximately $301,000. Finally, Indie Asset Partners LLC increased its position in shares of Cibus by 30.1% in the fourth quarter. Indie Asset Partners LLC now owns 16,929 shares of the company’s stock worth $332,000 after acquiring an additional 3,921 shares in the last quarter. 33.81% of the stock is owned by institutional investors and hedge funds.

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.